A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1

被引:4
作者
Heaney, Alice [1 ]
Wilburn, Jeanette [1 ]
Langmead, Shannon [2 ]
Blakeley, Jaishri [2 ]
Huson, Susan [3 ]
Jim, Carly [4 ]
McKenna, Stephen P. [1 ,5 ]
机构
[1] Galen Res, B1 Chorlton Mill,3 Cambridge St, Manchester M1 5BY, Lancs, England
[2] Johns Hopkins Comprehens Neurofibromatosis Ctr, Baltimore, MD USA
[3] St Marys Hosp, Manchester Ctr Genom Med, Manchester, Lancs, England
[4] Manchester Metropolitan Univ, Dept Psychol, Manchester, Lancs, England
[5] Univ Manchester, Sch Hlth Sci, Manchester, Lancs, England
来源
SAGE OPEN MEDICINE | 2019年 / 7卷
关键词
Needs; qualitative; needs assessment; quality of life; plexiform neurofibromas; PlexiQoL; OF-LIFE; PARENTAL REPORTS; CROHNS-DISEASE; HEALTH-CARE; CHILDREN; ADOLESCENTS; PREVALENCE; DEPRESSION; MANAGEMENT; SYMPTOMS;
D O I
10.1177/2050312119829680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To explore the impact of plexiform neurofibromas on the lives of adults with neurofibromatosis type 1. Background: Neurofibromatosis type 1 is a complex neurogenetic syndrome that affects many aspects of health and functioning. A common manifestation of neurofibromatosis type 1 is plexiform neurofibromas, non-cancerous tumours that can cause disfigurement, pain and neurologic disability. Patient-reported outcome measures used in this condition have addressed symptoms and functional ability but not how the condition affects patients' lives, particularly, their ability to meet their human needs. Methods: Unstructured qualitative interviews were conducted with adults with neurofibromatosis type 1-associated plexiform neurofibromas in the United Kingdom and United States. Interviewees were encouraged to describe how plexiform neurofibromas affected their ability to meet their needs. Interviews were audio-recorded and transcribed verbatim. The UK and US transcripts were combined and theoretical thematic analysis was conducted. Results: In all, 42 interviews (United Kingdom = 20, United States = 22) were conducted. Transcripts revealed 696 statements on the impact of plexiform neurofibromas on need fulfilment. Five major themes emerged: appearance, relationships, independence, role fulfilment and pleasure. Conclusion: Neurofibromatosis type 1-associated plexiform neurofibromas have a major effect on individuals' ability to meet their needs. An understanding of need fulfilment will complement information generated from traditional patient-reported outcome measures, particularly in a multi-faceted syndrome such as neurofibromatosis type 1.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study
    Weiss, Brian
    Widemann, Brigitte C.
    Wolters, Pamela
    Dombi, Eva
    Vinks, Alexander
    Cantor, Alan
    Perentesis, John
    Schorry, Elizabeth
    Ullrich, Nicole
    Gutmann, David H.
    Tonsgard, James
    Viskochil, David
    Korf, Bruce
    Packer, Roger J.
    Fisher, Michael J.
    NEURO-ONCOLOGY, 2015, 17 (04) : 596 - 603
  • [22] Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas
    Hou, Yang
    Allen, Taryn
    Wolters, Pamela L.
    Toledo-Tamula, Mary Anne
    Martin, Staci
    Baldwin, Andrea
    Reda, Stephanie
    Gillespie, Andy
    Goodwin, Anne
    Widemann, Brigitte C.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2020, 62 (08) : 977 - 984
  • [23] MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1
    V. F. Mautner
    M. Hartmann
    L. Kluwe
    R. E. Friedrich
    C. Fünsterer
    Neuroradiology, 2006, 48 : 160 - 165
  • [24] Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience
    Espirito Santo, Vera
    Passos, Joao
    Nzwalo, Hipolito
    Carvalho, Ines
    Santos, Filipa
    Martins, Carmo
    Salgado, Lucilia
    Silva, Conceicao e
    Vinhais, Sofia
    Vilares, Miguel
    Salgado, Duarte
    Nunes, Sofia
    JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (02) : 459 - 463
  • [25] Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience
    Vera Espírito Santo
    João Passos
    Hipólito Nzwalo
    Inês Carvalho
    Filipa Santos
    Carmo Martins
    Lucília Salgado
    Conceição e Silva
    Sofia Vinhais
    Miguel Vilares
    Duarte Salgado
    Sofia Nunes
    Journal of Neuro-Oncology, 2020, 147 : 459 - 463
  • [26] Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems
    Mautner, Victor-Felix
    Granstroem, Sofia
    Leark, Robert A.
    JOURNAL OF ATTENTION DISORDERS, 2015, 19 (01) : 35 - 43
  • [27] French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA study
    Wolkenstein, Pierre
    Chaix, Yves
    Werle, Natacha Entz
    Amini-Adle, Mona
    Barbarot, Sebastien
    Boileau, Christine
    Miled, Anissa
    Rashid, Talha
    Aerts, Isabelle
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2023, 66 (05)
  • [28] Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review
    Solaresy, I.
    Vinal, D.
    Morales-Conejo, M.
    Rodriguez-Salas, N.
    Feliu, J.
    ESMO OPEN, 2021, 6 (04)
  • [29] Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two Methods
    Cai, Wenli
    Steinberg, Seth M.
    Bredella, Miriam A.
    Basinsky, Gina
    Somarouthu, Bhanusupriya
    Plotkin, Scott R.
    Solomon, Jeffrey
    Widemann, Brigitte C.
    Harris, Gordon J.
    Dombi, Eva
    ACADEMIC RADIOLOGY, 2018, 25 (02) : 144 - 152
  • [30] Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas
    Armstrong, Amy E.
    Belzberg, Allan J.
    Crawford, John R.
    Hirbe, Angela C.
    Wang, Zhihong J.
    BMC CANCER, 2023, 23 (01)